CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 3,615.00
-120.00 (-3.21%)
At close: Apr 2, 2026
KOSDAQ:261780 Market Cap
KOSDAQ:261780 has a market cap or net worth of 97.12 billion as of April 2, 2026. Its market cap has increased by 16.79% in one year.
Market Cap
97.12B
Enterprise Value
82.29B
Revenue
158.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,615.00
Market Cap Chart
Since October 22, 2021, KOSDAQ:261780's market cap has decreased from 343.58B to 97.12B, a decrease of -71.73%. That is a compound annual growth rate of -24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 100.34B | 32.21% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 122.14B |
| BIO-FD&C | 121.13B |
| NovMetaPharma | 112.88B |
| ViGenCell | 110.08B |
| CORESTEMCHEMON | 105.13B |
| Quratis | 102.92B |
| TegoScience | 100.16B |
| Cell Biotech | 95.81B |